Remedy Meds

Name

Remedy Meds

Legal name

Remedy Meds LLC

Website

https://remedymeds.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Telehealth Weight Loss

NAICS

Other Ambulatory Health Care Services (6219), Offices of Physicians (6211)

SIC

Services-Health Services (8000)

akta.pro primary industry

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

akta.pro secondary industries

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK)

Keywords

• Telehealth weight loss
• GLP-1 medications
• Compounded semaglutide
• Online weight management
• Direct-to-consumer pharmacy

Headquarters

HQ city

Summit

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Subscription Membership Fees: Monthly subscription program fees billed upfront for each subscription term. Covers personalized GLP-1 prescription, unlimited clinician access, monthly live expert sessions, 10,000+ member community access, and medication shipments. Cash-pay only; does not accept insurance.
2. Brand-Name GLP-1 Medications: Optional retail pricing for brand-name medications such as Ozempic and Zepbound for customers who prefer FDA-approved products over compounded alternatives.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Remedy Meds operates a direct-to-consumer telehealth platform that connects adult consumers with licensed clinicians for personalized GLP-1 weight loss treatment. Members complete a 90-second online intake quiz, are matched with a clinician-led treatment plan (compounded semaglutide or tirzepatide), and receive prescription medication shipped directly to their homes on a month-to-month subscription basis. The platform bundles unlimited clinician consultations, monthly live expert sessions, and a member community into a single cash-pay program available across all 50 U.S. states plus DC.

Product overview

Remedy Meds operates as a consumer health and pharmacy platform offering a multi-brand telehealth ecosystem. The core offering is the Remedy Meds platform providing personalized GLP-1 weight loss treatment through compounded Semaglutide and Tirzepatide medications, along with a microdose entry option. Following the September 2025 acquisition of Thirty Madison for over $500 million, the platform expanded to include Keeps (men's hair loss), Nurx (women's health), and Cove (migraine management) brands, creating a unified care platform spanning metabolic health, women's health, men's health, and chronic condition management.

Differentiator

Problem solved

Functional benefit

Products and services

• Remedy Meds GLP-1 Weight Loss Program Subscription-based telehealth weight loss program offering personalized GLP-1 treatment matched to individual body and goals, unlimited clinician-led video calls and messaging, monthly live expert sessions, member community access, and home-delivered medication. Targets adults with BMI 30+ (obesity) or BMI 27+ with weight-related conditions.
• Compounded Semaglutide Compounded GLP-1 receptor agonist medication for chronic weight management, dispensed via once-weekly subcutaneous injection as part of a personalized dosing protocol. Sourced from licensed U.S. compounding pharmacies and batch-tested for potency, sterility, pH balance, and endotoxicity.
• Compounded Tirzepatide Compounded dual GIP + GLP-1 receptor agonist medication for weight loss, positioned as the strongest compounded option targeting both hunger and insulin pathways for faster results. Dispensed via once-weekly subcutaneous injection from licensed U.S. compounding pharmacies with four-step batch testing.
• GLP-1 Microdose Plan Entry-level GLP-1 treatment using half the standard dose administered twice weekly, designed to minimize side effects and provide an easier adjustment period for new users. Part of the Remedy Meds telehealth weight loss program.
• Keeps Men's hair loss treatment brand offering FDA-approved hair loss medications via telehealth consultation and home delivery. Part of the Remedy Meds multi-brand telehealth ecosystem following the Thirty Madison acquisition.
• Nurx Women's health brand providing reproductive and sexual health medications including birth control, PrEP, and HPV screening via telehealth consultation and home delivery. Part of the Remedy Meds multi-brand telehealth ecosystem following the Thirty Madison acquisition.
• Cove Migraine management brand offering migraine medications and ongoing care through virtual visits and prescription home delivery. Part of the Remedy Meds multi-brand telehealth ecosystem following the Thirty Madison acquisition.

Quantifiable outcome

• Members lose average 14 lbs in 90 days (2x industry average)
• +4 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core and flagship.

• Health-E CommercecoreChannel Partner/ Reseller/ Distributor · 21 October 2025Health-E Commerce expanded its telehealth weight loss options to include Remedy Meds, making the service available on FSA Store and HSA Store platforms. This partnership enables customers to use Flexible Spending Accounts and Health Savings Accounts for payment.
• Thirty MadisonflagshipOthers · 3 September 2025Remedy Meds acquired Thirty Madison in an all-stock transaction valued just north of $500 million. The deal combines Remedy Meds' weight loss and metabolic health platform with Thirty Madison's virtual specialty care services, creating a multi-brand telehealth ecosystem spanning women's health, men's health, migraine management, and weight loss. Combined entity has over $670 million in annual revenue with strong profitability.
• OpenLoop Healthcare Partners, PCcoreImplementation/ SI/ Consulting PartnerProfessional entity providing clinical services through the Remedy Meds platform. One of the Professional Entities that delivers telehealth services including medical evaluation, diagnosis, and prescribing.
• JMP Medical, P.A.coreImplementation/ SI/ Consulting PartnerProfessional entity providing clinical services through the Remedy Meds platform. One of the Professional Entities that delivers telehealth services including medical evaluation, diagnosis, and prescribing.
• KMG Medical Group MO, P.C.coreImplementation/ SI/ Consulting PartnerProfessional entity providing clinical services through the Remedy Meds platform. One of the Professional Entities that delivers telehealth services including medical evaluation, diagnosis, and prescribing.
• U.S. Licensed Compounding PharmaciescoreTechnology or IntegrationLicensed U.S. pharmacies that fulfill prescriptions for compounded GLP-1 medications. All batches pass four independent tests before shipping: potency verification, sterility testing, pH balance, and endotoxicity screening.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hims & Hers Health: Public direct-to-consumer telehealth platform (HIMS) offering GLP-1 weight loss treatments, men's and women's health, and dermatology. The closest comparable in business model, customer base and GLP-1 go-to-market, and the named competitor in Remedy Meds' positioning.
• Ro: Direct-to-consumer telehealth platform offering Ro Body (weight management with GLP-1s) along with men's health, women's health and smoking cessation. Directly competes with Remedy Meds in cash-pay GLP-1 subscriptions.
• Noom: Digital health platform with Noom Med, a clinician-supervised GLP-1 program. Comparable in combining a behavioral/app layer with prescription weight-loss medication delivered to consumers.
• Calibrate: Metabolic health platform pairing clinician-prescribed GLP-1s with biweekly coaching and a curriculum. Closely overlaps Remedy Meds' weight-loss-plus-clinician-led-care model.
• Found: Telehealth weight management platform offering clinician-prescribed GLP-1s alongside behavioral coaching. Similar cash-pay subscription model targeting the same obesity/overweight population.
• Mochi Health: Telehealth platform focused on prescription weight loss including compounded GLP-1s, with clinician follow-up. Direct competitor for cash-pay compounded semaglutide/tirzepatide patients.
• Henry Meds: Direct-to-consumer telehealth provider of compounded GLP-1 weight loss medications with clinician oversight. Closely comparable offerings and target customer as Remedy Meds.

Broad incumbents

• WeightWatchers: Established weight management brand that has launched a clinician-led GLP-1 telehealth program (WeightWatchers Clinic). Comparable as it pairs behavioral support with prescription weight loss, competing for the same end consumer.

Others

• Thirty Madison: Multi-brand telehealth operator (Keeps, Nurx, Cove) acquired by Remedy Meds in September 2025 for ~$500M. Comparable as a specialty telehealth platform that Remedy Meds is now integrating and operating as a subsidiary.
• Health-E Commerce (FSA Store / HSA Store): Distribution partner that lists Remedy Meds on FSA Store and HSA Store. Adjacent rather than competitive — included to illustrate the payment-access infrastructure enabling Remedy Meds' cash-pay model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/groups/officialremedymeds

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Remedy Meds